[ACCESS RESTRICTED TO THE UNIVERSITY OF MISSOURI AT AUTHOR'S REQUEST.] There are many areas where optimal designs are applied to, for example, the development of a new drug, where a conventional dose- finding study involves learning about the dose-response curve in order to bring forward right doses of drug to late-stage development. The first part of this dissertation focus on three pharmacodynamics sigmoid Emax models, we derive the corresponding simple formats of the adaptive optimal designs regardless of the optimality criteria or parameters of interest. An algorithm for deriving a specific adaptive optimal design is developed. A simulation study comparing the adaptive optimal designs and the uniform designs is also performed. The secon...
Abstract: The multi-chart consists of several CUSUM or EWMA charts with dif-ferent reference values ...
Understanding and properly characterizing the dose–response relationship is a fundamental step in th...
Optimizing designs using robust (global) optimality criteria has been shown to be a more flexible ap...
The pharmaceutical industry now recognises the importance of the newly defined discipline of pharmac...
We consider optimal design problems for dose-finding studies with censored Weibull time-to-event out...
This thesis concerns optimal designs and estimation approaches for a class of nonlinear dose respons...
One of the most complex tasks during the clinical development of a new drug is to find a correct dos...
In this Ph.D. thesis, we investigate how to optimize the design of clinical trials by constructing o...
During the development process for new drugs, dose-finding trials have to be conducted and the choic...
summary:The moving average (MA) chart, the exponentially weighted moving average (EWMA) chart and th...
Design of phase 1 combination therapy trials is complex compared to single therapy trials. In this w...
Improving methodology for Phase I dose-finding studies is currently of great interest in pharmaceuti...
We consider a dose-finding trial in phase IIB of drug development. For choosing an appropriate desi...
This project proposed the optimization design of the Cumulative Sum (CUSUM) control chart by finding...
This article presents the optimization design of the combined Shewhart chart and CUSUM chart ( chart...
Abstract: The multi-chart consists of several CUSUM or EWMA charts with dif-ferent reference values ...
Understanding and properly characterizing the dose–response relationship is a fundamental step in th...
Optimizing designs using robust (global) optimality criteria has been shown to be a more flexible ap...
The pharmaceutical industry now recognises the importance of the newly defined discipline of pharmac...
We consider optimal design problems for dose-finding studies with censored Weibull time-to-event out...
This thesis concerns optimal designs and estimation approaches for a class of nonlinear dose respons...
One of the most complex tasks during the clinical development of a new drug is to find a correct dos...
In this Ph.D. thesis, we investigate how to optimize the design of clinical trials by constructing o...
During the development process for new drugs, dose-finding trials have to be conducted and the choic...
summary:The moving average (MA) chart, the exponentially weighted moving average (EWMA) chart and th...
Design of phase 1 combination therapy trials is complex compared to single therapy trials. In this w...
Improving methodology for Phase I dose-finding studies is currently of great interest in pharmaceuti...
We consider a dose-finding trial in phase IIB of drug development. For choosing an appropriate desi...
This project proposed the optimization design of the Cumulative Sum (CUSUM) control chart by finding...
This article presents the optimization design of the combined Shewhart chart and CUSUM chart ( chart...
Abstract: The multi-chart consists of several CUSUM or EWMA charts with dif-ferent reference values ...
Understanding and properly characterizing the dose–response relationship is a fundamental step in th...
Optimizing designs using robust (global) optimality criteria has been shown to be a more flexible ap...